Insider Cluster (2 insiders) ·Filed May 11, 2026

ANIP

ANI PHARMACEUTICALS INC
NEUTRAL
Impact 4/10
Horizonweeks Processed4mo ago
Insider cluster: 2 insiders, $4.6M total
Actionable Insight • Neutral

A cluster of insider sales at ANI Pharmaceuticals, led by CEO Nikhil Lalwani selling $4.27M worth of shares, follows a strong Q1 2026 earnings beat and raised guidance. The total insider selling of ~$5.7M over the cluster window represents about 0.3% of market cap, which is modest but notable given the CEO's participation. The sales are likely liquidity-driven after a significant stock run-up post-earnings, but the cluster's timing and size warrant monitoring for any upcoming negative catalysts.

DirectionNeutral
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
ANIP ▲ +1.49% at T+60d
NEUTRAL call ✓ call won +1.49% · α vs SPY -2.91% · entry $78.71 → $79.88
Entry anchored
May 8, 03:59 PM ET
via exchange tick
T+1d
+1.00%
call +1.00% · α +1.14%
$79.50
settled 5mo ago
T+5d
+0.80%
call +0.80% · α +0.89%
$79.34
settled 5mo ago
T+20d
+3.16%
call +3.16% · α +3.47%
$81.20
settled 4mo ago
T+60d
+1.49%
call +1.49% · α -2.91%
$79.88
settled 8w ago

Price Chart

Loading chart...

Executive Summary

A cluster of insider sales at ANI Pharmaceuticals, led by CEO Nikhil Lalwani selling $4.27M worth of shares, follows a strong Q1 2026 earnings beat and raised guidance. The total insider selling of ~$5.7M over the cluster window represents about 0.3% of market cap, which is modest but notable given the CEO's participation. The sales are likely liquidity-driven after a significant stock run-up post-earnings, but the cluster's timing and size warrant monitoring for any upcoming negative catalysts.

Key Financial Metrics

Direction
selling
Total Value
$5.7M
Insiders
2

Key Facts

  • CEO Nikhil Lalwani sold 55,000 shares for $4.27M on May 11, 2026.
  • Director Patrick Walsh sold a total of ~14,000 shares for $1.13M over May 11-13.
  • Total insider sales in the cluster: ~$5.7M, or ~0.3% of ANIP's $1.8B market cap.
  • Q1 2026 revenue was $237.5M (+20.5% YoY), beating consensus of $207.6M.
  • GAAP diluted EPS of $1.28 beat consensus of $1.30.
  • Company raised full-year 2026 guidance and authorized a $100M buyback.
  • Prior 30-day insider activity showed $5.7M in total sales before this cluster.
  • Historical calibration shows score-6 reports in this segment have only a 29% win rate at T+20.

Financial Impact

Insider sales of ~$5.7M represent 0.3% of market cap — modest but concentrated in CEO and director.

dilutioninsider sentiment

Risk Factors

  • CEO selling a large portion of his stake could signal peak valuation or upcoming headwinds.
  • Cluster sales may be followed by more insider selling if the stock continues to rally.
  • Historical calibration suggests score-6 reports in this segment have poor predictive accuracy (29% win rate at T+20).

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ANIP-1778718158958
21 reports for ANIP
Performance horizon
43% Hit rate 3 of 7 directional calls best @ T+60▲ +8.88%Apr 8, 2026
Filters
Rows
Reports for ANIP — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$72.11 $77.91▲ +8.04%▲ +7.23%$71.97 (−0.19%)
Sep 1, 2026
4w ago
Insider Cluster
NEUTRAL ★ 3/10
$73.06 $71.46▼ −2.19%▼ −1.23%$71.97 (−1.49%)
Aug 24, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$74.17 $73.25▼ −1.24%▼ −1.71%$71.97 (−2.97%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$74.77 $77.32▲ +3.41%▲ +5.37%$71.97 (−3.74%)
Aug 7, 2026
8w ago
8-K
BULLISH ★ 6/10
$78.25 $76.54▼ −2.19%▼ −2.58%$71.97 (−8.03%)
Jul 16, 2026
11w ago
Court Ruling
NEUTRAL ★ 2/10
$81.92 $78.53▼ −4.14%▼ −2.47%$71.97 (−12.15%)
Jul 13, 2026
11w ago
Press Release
BULLISH ★ 6/10
$81.08 $79.20▼ −2.32%▼ −1.53%$71.97 (−11.24%)
Jun 15, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$83.00 $82.94▼ −0.07%▲ +2.16%$71.97 (−13.29%)
Jun 11, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$81.65 $80.52▼ −1.38%▼ −1.82%$71.97 (−11.86%)
May 21, 2026
19w ago
8-K
NEUTRAL ★ 3/10
$82.72 $76.71▼ −7.27%▼ −8.92%$71.97 (−13.00%)
Showing 10 of 21

US Market Status

Market Open — Closes in 2h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 14, 2026